Loading
A phase 2 trial of OST31-164 as maintenance after surgery for recurrent osteosarcoma, run by Emerald Clinical Inc., active and no longer recruiting.
Osteosarcoma Maintenance Therapy With OST31-164 is a phase 2 interventional study registered as NCT04974008 by Emerald Clinical Inc., with 39 participants enrolled, started 2021-10-21 and due to reach its primary completion in 2023-09-21. Interventions recorded: OST31-164.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Osteosarcoma and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/